Ignite Creation Date:
2025-12-24 @ 5:49 PM
Ignite Modification Date:
2025-12-28 @ 10:08 PM
Study NCT ID:
NCT04952168
Status:
UNKNOWN
Last Update Posted:
2021-07-07
First Post:
2021-06-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of Almonertinib and Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC
Sponsor:
Yuan Chen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-02
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-06-02
Completion Date Type:
ESTIMATED
First Submit Date:
2021-06-27
First Submit QC Date:
None
Study First Post Date:
2021-07-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-04
Last Update Post Date:
2021-07-07
Last Update Post Date Type:
ACTUAL